Browsing by Author "Londoño, María-Carlota"

Sort by: Order: Results:

  • Aplastic Anemia and Severe Myelosuppression with Boceprevir or Simeprevir-Containing Hepatitis C Virus Treatment
    Senín Magan, Maria Alicia; Broquetas, Teresa; Cañete Hidalgo, Nuria; Lens, Sabela; Londoño, María-Carlota; Ferraro Rosset, Mariana Paola; Forns, Xavier; Salar Silvestre, Antonio; Carrión Rodríguez, José Antonio (Asociación Mexicana de Hepatología, 2017)
    The addition of the new protease inhibitors (PIs) to peg-interferon (IFN) and ribavirin (RBV), approved for chronic hepatitis C, has clearly improved sustained virological response (SVR) rates although several adverse ...
  • Aplastic anemia and severe pancytopenia during treatment with peg-interferon, ribavirin and telaprevir for chronic hepatitis C.
    Lens, Sabela; Calleja, Jose Luis; Campillo, Ana; Carrión Rodríguez, José Antonio; Broquetas, Teresa; Perello, Christie; de la Revilla, Juan; Mariño, Zoe; Londoño, María-Carlota; Sánchez-Tapias, José Maria; Urbano-Ispizua, Álvaro; Forns, Xavier (Baishideng Publishing Group, 2015)
    elaprevir and Boceprevir are the first direct acting antivirals approved for chronic hepatitis C in combination with peg-interferon alfa and ribavirin. Pancytopenia due to myelotoxicity caused by these drugs may occur, but ...
  • Neutrophil and monocyte function in patients with chronic Hepatitis C undergoing antiviral therapy with regimens containing protease inhibitors with and without Interferon
    Gambato, Martina; Caro-Pérez, Noelia; González, Patricia; Cañete Hidalgo, Nuria; Mariño, Zoe; Lens, Sabela; Bonacci, Martín; Bartres, Concepció; Sánchez-Tapias, José-María; Carrión Rodríguez, José Antonio; Forns, Xavier; Juan, Manel; Pérez-del-Pulgar, Sofía; Londoño, María-Carlota (Public Library of Science (PLoS), 2016)
    Real-life data showed an increased incidence of bacterial infections in patients with advanced liver disease receiving a protease inhibitor (PI)-containing antiviral regimen against hepatitis C (HCV). However, the causes ...
  • Noninvasive prediction of outcomes in autoimmune hepatitis-related cirrhosis
    Llovet, Laura-Patricia; Gratacós-Ginès, Jordi; Téllez, Luis; Gómez-Outomuro, Ana; Navascués, Carmen A.; Riveiro-Barciela, Mar; Vinuesa, Raquel; Gómez-Camarero, Judith; García-Retortillo, Montserrat; Díaz-Fontenla, Fernando; Salcedo, Magdalena; García-Eliz, María; Horta, Diana; Guerrero, Marta; Rodríguez-Perálvarez, Manuel; Fernández-Rodriguez, Conrado; Albillos, Agustín; Abraldes, Juan Gonzales; Parés Jiménez, Albert; Londoño, María-Carlota (Wiley, 2022)
    The value of noninvasive tools in the diagnosis of autoimmune hepatitis (AIH)-related cirrhosis and the prediction of clinical outcomes is largely unknown. We sought to evaluate (1) the utility of liver stiffness measurement ...